Trending Down-0.3800 (-1.8710%)
  • Bid / Lots
    19.8900/ 2
  • Ask / Lots
    19.9800/ 5
  • Open / Previous Close
    20.3000 / 20.3100
  • Day Range
    Low 19.9300
    High 20.6900
  • 52 Week Range
    Low 7.6700
    High 34.7200
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 20.31
09:32 ET197320.69
09:34 ET40020.68
09:36 ET20020.19
09:38 ET10020.285
09:39 ET90020.13
09:41 ET20020.4
09:50 ET10020.31
09:54 ET30020.42
09:56 ET282920.31
09:57 ET558220.44
10:01 ET20020.385
10:03 ET30020.38
10:06 ET10020.49
10:08 ET20020.38
10:12 ET10020.39
10:14 ET48520.45
10:15 ET10020.46
10:17 ET20020.45
10:19 ET30020.43
10:28 ET30020.35
10:32 ET10020.315
10:33 ET49820.14
10:35 ET10020.13
10:37 ET20020.26
10:44 ET40020.14
10:46 ET20020.16
10:57 ET40020.17
11:04 ET11020.19
11:06 ET10020.25
11:08 ET10020.25
11:11 ET10120.275
11:15 ET80020.26
11:18 ET109020.295
11:20 ET50020.35
11:22 ET34420.36
11:26 ET493720.3
11:27 ET820920.3
11:29 ET20020.31
11:31 ET251820.2
11:33 ET439820.1
11:36 ET56620.16
11:38 ET13020.26
11:40 ET30020.41
11:44 ET10020.33
11:45 ET10020.42
11:49 ET72020.34
11:51 ET16320.2796
11:56 ET50020.29
12:00 ET40020.24
12:07 ET10020.3
12:09 ET10020.225
12:34 ET20020.23
12:36 ET20020.24
12:50 ET10020.24
12:52 ET45920.13
12:54 ET10020.185
12:59 ET50020.19
01:01 ET40020.19
01:08 ET152020.105
01:14 ET10020.09
01:17 ET60020.015
01:21 ET30020.01
01:30 ET40020.06
01:35 ET40019.98
01:39 ET60020.02
01:46 ET10019.985
01:48 ET20019.93
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINBX
Inhibrx Inc
United StatesEQRX
EQRx Inc
United StatesVERV
Verve Therapeutics Inc
United StatesBLU
BELLUS Health Inc
United StatesCRNX
Crinetics Pharmaceuticals Inc
United StatesGPCR
Structure Therapeutics Inc
As of 2023-03-28

Company Information

Inhibrx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of biologic therapeutic candidates in oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, INBRX-109, INBRX-105 and INBRX-106. INBRX-101 is an engineered recombinant human alpha-1 antitrypsin fragment crystallizable (AAT-Fc) fusion protein therapeutic candidate that the Company is developing for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD) and acute Graft-versus -host-disease (aGvHD). INBRX-109 is an engineered tetravalent therapeutic candidate targeting death-receptor 5 (DR5), a TNFRSF member, also known as tumor necrosis factor-related apoptosis-inducing ligand or TRAIL receptor 2. INBRX-105 is a conditional tetravelent PD-L1 targeted 4-1BB agonist that is being investigated as a single agent and in combination with Keytruda in patients with locally advanced or metastatic solid tumors.

Contact Information

11025 N. Torrey Pines Road, Suite 200LA JOLLA, CA, United States 92037


Chairman of the Board of Director, President, Chief Executive Officer, Co-Founder
Mark Lappe
Co-Founder, Chief Scientific Officer
Brendan Eckelman
Chief Financial Officer
Kelly Deck
Independent Director
Douglas Forsyth
Independent Director
Jon Kayyem

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.